Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
ARTICLE

Cross-Modulation of Synaptic Plasticity by β-Adrenergic and 5-HT1A Receptors in the Rat Basolateral Amygdala

Su-Jane Wang, Li-Liang Cheng and Po-Wu Gean
Journal of Neuroscience 15 January 1999, 19 (2) 570-577; DOI: https://doi.org/10.1523/JNEUROSCI.19-02-00570.1999
Su-Jane Wang
1Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan City, Taiwan 701
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li-Liang Cheng
1Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan City, Taiwan 701
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Po-Wu Gean
1Department of Pharmacology, College of Medicine, National Cheng-Kung University, Tainan City, Taiwan 701
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Neurotransmitter receptors are often colocalized in a neuron with other receptors, and activation of one receptor can either amplify or antagonize the response to a colocalized receptor. The aim of this study was to investigate the cross-regulation of synaptic transmission by β-adrenergic and serotonin 1A (5-HT1A) receptors and to elucidate their underlying mechanisms. Stimulation of presynaptic β-adrenergic receptors with isoproterenol (Iso) in the basolateral amygdala resulted in a long-lasting increase in synaptic transmission. This effect was mimicked by forskolin, an activator for adenylyl cyclase and a cAMP analog. In addition, the effect of forskolin was blocked by catalytic and regulatory site antagonists for cAMP-dependent protein kinase (PKA), indicating a PKA-mediated mechanism. Application of 5-HT depressed the synaptic transmission and blocked Iso- and forskolin-induced potentiation. The effect of 5-HT was mimicked by the selective 5-HT1A agonist 8-hydroxy-dipropylaminotetralin and was blocked by the selective 5-HT1A antagonist 1-(2-methoxyphenyl)-4[4-(2-phthalimido)butyl]piperazine, indicating its mediation by 5-HT1A receptors. To determine the locus of interaction, Sp-cAMPS, a membrane-permeable activator of PKA, was applied, and the potentiation produced by Sp-cAMPS was completely blocked in slices pretreated with 5-HT. These results suggest that the interaction between the intracellular signaling pathways activated by 5-HT1A and β-adrenergic receptors occurs at a step downstream from cAMP production.

  • serotonin
  • isoproterenol
  • cAMP
  • protein kinase A
  • calcium channel
  • long-term potentiation
  • amygdala

Serotonin 1A (5-HT1A) receptor belongs to a family of neurotransmitter receptors that act through G-proteins of the Gi/Go class to inhibit adenylyl cyclase (Andrade et al., 1986; Taussig et al., 1993). In the amygdala, application of 5-HT and 5-HT1A receptor agonists caused a depression of EPSP with no concomitant changes in the resting membrane potential or neuronal input resistance (Rainnie, 1995; Cheng et al., 1998). In addition, postsynaptic depolarization evoked by glutamate receptor agonists was unaltered in the presence of 5-HT, indicating an effect on the excitatory synapses rather than a change in the excitability of basolateral amygdala neurons (Cheng et al., 1998). On the other hand, activation of β-adrenergic receptors that are coupled positively to adenylyl cyclase through Gs proteins induced long-term enhancement of synaptic transmission in these same neurons (Huang et al., 1996).

Cross-talk between G-protein-coupled receptors has been demonstrated in a number of systems. For example, stimulation of α-adrenoceptors in hippocampal CA1 neurons strongly upregulated the effect of β-adrenoceptors on afterhyperpolarzing currents (IAHP) (Pedarzani and Storm, 1996). Heterologous regulation has also been reported between GABABand β-adrenoceptors in the hippocampus in which agonist stimulation of Gi-linked receptors may upregulate or downregulate β-adrenergic responses (Andrade, 1993; Gerber and Gahwiler, 1994). Similarly, in ileal and tracheal smooth muscles, antagonism of M2 muscarinic receptors leads to an increase in the relaxant potency of β agonists (Fernandes et al., 1992). In the basolateral amygdala, functional 5-HT1A and β-adrenergic receptors are present in the excitatory nerve endings (Huang et al., 1996; Cheng et al., 1998), which represent a useful system to investigate cross-talk between these receptors. Therefore, in this study, we investigated the effect of Gi-linked receptors on β-adrenoceptor-induced synaptic plasticity and elucidated their underlying mechanisms.

MATERIALS AND METHODS

Male Sprague Dawley rats, 4–6 weeks of age, were decapitated, and their brains were rapidly removed and placed in cold oxygenated artificial CSF (ACSF) solution. Subsequently, the brain was hemisected and cut transversely posterior to the first branch and anterior to the last branch of the superior cerebral vein. The resulting section was glued to the chuck of a Vibroslice tissue slicer (Campden Instruments, Silbey, UK). Transverse slices of 500 μm thickness were cut, and the appropriate slices were placed in a beaker of oxygenated ACSF at room temperature for at least 1 hr before recording. ACSF solution had the following composition (in mm): NaCl 117, KCl 4.7, CaCl2 2.5, MgCl2 1.2, NaHCO3 25, NaH2PO4 1.2, and glucose 11. The ACSF was bubbled with 95% O2 and 5% CO2 and had the pH of 7.4.

A single slice was transferred to the recording chamber, in which it was held submerged between two nylon nets and maintained at 32 ± 1°C. The chamber consisted of a circular well of a low volume (1–2 ml) and was perfused constantly at a rate of 2–3 ml/min. Intracellular recording microelectrodes were pulled from 1.0 mm microfiber capillary tubing on a Flaming–Brown electrode puller (Sutter Instruments, San Rafael, CA). The electrodes were filled with 4 m potassium acetate with resistance ranging from 70 to 130 MΩ. For chelating intracellular Ca2+, the electrodes were filled with 50 mm BAPTA in addition to 3 m potassium acetate. When BAPTA-containing electrodes were used, loading of the cells with BAPTA was assayed by the blockade of Ca2+-activated afterhyperpolarization and spike-frequency accommodation. The microelectrode tips were positioned into the basolateral subdivision of amygdala (BLA). Monosynaptic EPSPs were evoked in BLA neurons by electrical stimulation of afferents from the lateral nucleus of amygdala with a concentric bipolar stimulating electrode (SNE-100; Kopf Instruments, Bern, Germany). Electrical stimuli (150 μsec) were delivered at a frequency of 0.05 Hz. Extracellular recordings of field potentials were obtained using microelectrodes filled with 3 m NaCl (3–8 MΩ). The stimulus intensity was adjusted individually for each experiment to produce field potential amplitude that was 40–50% of the maximal response. Experimental treatments were not initiated until the response had been stable for at least 20 min. The strength of synaptic transmission was quantified by measuring the amplitude of field potentials. The amplitude of field potential was measured as the difference between negative peak and the average value of the following positive peak. Electrical signals were amplified by using an Axoclamp-2A amplifier (Axon Instruments, Foster City, CA) and recorded on a Gould 3200 chart recorder. All data were expressed as mean ± SE. Statistical analysis was performed using the Student’st test, and p < 0.05 was considered statistically significant.

5-HT and forskolin were obtained from Sigma (St. Louis, MO), and other chemicals were purchased from Research Biochemicals (Natick, MA).

RESULTS

PKA mediates isoprotenol-induced synaptic potentiation

Previous studies from this laboratory have demonstrated that administration of the β-adrenergic agonist isoproterenol (Iso) to the BLA neurons resulted in long-term enhancement of synaptic transmission (Huang et al., 1996). We tested whether β-adrenergic response is mediated by stimulation of adenylyl cyclase, resulting in an increase in intracellular cAMP by application of forskolin, a direct activator of adenylyl cyclase. Figure1A shows that forskolin (25 μm) produced an effect similar to that of Iso. In seven cells, the amplitude of EPSP was increased to 188% of baseline, which remained potentiated for at least 30 min after washout of the drug (control, 4.8 ± 0.6 mV; 30 min after treatment with forskolin, 9.0 ± 0.9 mV, n = 7, p< 0.001). The sustained enhancement of EPSP could be caused by a slow washout of Iso or forskolin. To examine this possibility, a β-receptor blocker propranolol was applied during the washing period. In three neurons tested, propranolol (1 μm) did not affect Iso-induced potentiation (data not shown), suggesting that the long-term effect was not caused by a continued activation of receptors. Moreover, extracellular field recordings were made because it could be maintained for a long period of time. Electrical stimulation of the lateral nucleus resulted in a biphasic response, presumably a presynaptic fiber volley followed by a postsynaptic potential. Bath application of the ionotropic glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 μm) abolished the latter component, demonstrating that this component was mediated by excitatory synaptic transmission (Fig.1B). Figure 1C shows that forskolin induced a long-term enhancement of field potentials. The amplitude of field potentials was 191 ± 15% (n = 7) of control 105 min after application of forskolin. To test the involvement of cAMP-independent action of forskolin, 1,9-dideoxy-forskolin (25 μm), which has no effect on adenylyl cyclase but does mimic many cAMP-independent actions of forskolin (Laurenza et al., 1989), was applied. In four neurons, 1,9-dideoxy-forskolin did not significantly affect the amplitude of field potentials (104 ± 8%).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Long-term potentiation of EPSP induced by forskolin in BLA neurons. A, The amplitude of EPSP was plotted as a function of time. Bar denotes period of application of forskolin (25 μm). Insetshows superimposed records taken at different times as indicated. The EPSP was preceded by a transient hyperpolarizing current pulse (0.2 nA, 50 msec) passed through the recording electrode to monitor input resistance. B, Extracellular recordings of a typical biphasic potential, demonstrating that the latter event was sensitive to CNQX (10 μm). C, LTP of extracellularly recorded potentials induced by forskolin (25 μm).

As a further test of the involvement of cAMP, the effect of membrane-permeable cAMP analog Sp-cAMPS (25 μm) on the EPSP was investigated. Figure2A shows that superfusion of Sp-cAMPS produced a reversible depression of EPSP, presumably caused by an action at adenosine A1 receptors (Dunwiddie and Hoffer, 1980; Pockett et al., 1993), and no LTP was seen after washout of the drug. Sp-cAMPS was therefore coapplied with 3-isobutyl-1-methylxanthine (IBMX, 50 μm), an adenosine A1 receptor antagonist and phosphodiesterase inhibitor. IBMX alone increased the amplitude of EPSP to 146 ± 10% (n = 6) of control, which was completely reversible on washout of the IBMX. As shown in Figure 2B, concurrent application of Sp-cAMPS and IBMX did not result in a depression such as that caused by Sp-cAMPS alone. By contrast, they induced a long-term enhancement of EPSP (177 ± 15% of control;n = 7; p < 0.001).

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Effect of Sp-cAMPS on the EPSP. A, Application of Sp-cAMPS (25 μm) caused a depression of EPSP that returned to control level after washout of the drug without initiating LTP. B, The depression caused by Sp-cAMPS was prevented by IBMX (50 μm) and, in the presence of IBMX, Sp-cAMPS induced LTP.

Finally, a catalytic site antagonist for PKA was applied to confirm the involvement of PKA in the action of Iso. In these experiments, slices were presoaked in 1 μm KT 5720 for at least 1 hr before being transferred to the recording chamber where the drug was maintained at the same concentration. Figure3 shows that Iso-induced potentiation was completely blocked in KT 5720-pretreated slices. In control slices, the EPSP amplitude was increased to 194% of baseline by Iso (15 μm) (EPSP amplitude was 6.7 ± 0.6 mV before and 13.0 ± 0.9 mV 30 min after treatment with Iso, n= 7), whereas in KT 5720-pretreated slices the EPSP amplitude was 6.0 ± 1.3 mV before and 6.0 ± 1.4 mV (n = 7) in the presence of Iso. The difference in the effect of Iso between two groups was statistically significant (p < 0.01, unpaired t test). Similar result was obtained when slices were preincubated with 25 μm Rp-cAMPS, a PKA regulatory site antagonist (EPSP amplitude was 6.2 ± 0.9 mV before and 7.0 ± 1.0 mV in the presence of Iso, n= 6) (Fig. 3).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Blockade of Iso-induced potentiation by PKA inhibitors. Slices were incubated for at least 1 hr in 25 μm Rp-cAMPS or 1 μm KT 5720 before being transferred to the recording chamber where the same concentration of drugs was maintained. Iso-induced potentiation normally observed in control slices was blocked in the Rp-cAMPS- or KT 5720-treated slices.

Blockade of Iso- and forskolin-induced potentiation by 5-HT

We examined the influence of 5-HT on Iso-induced potentiation because a subtype of 5-HT receptors (5-HT1A) has been shown to reduce forskolin-stimulated cAMP formation in the hippocampus (De Vivo and Maayani, 1986). Figure4A shows that superfusion of 5-HT (10 μm) depressed the EPSP amplitude to 52% of control (control, 8.8 ± 1.4 mV; in the presence of 5-HT, 4.6 ± 0.5 mV, n = 6). Iso was then added to the bath but failed to enhance the EPSP. In the presence of 5-HT, the EPSP amplitude in Iso remained 100 ± 10% (n = 6), which was significantly different from those in the absence of 5-HT (194 ± 13%; n = 7; p < 0.001). Similarly, in the presence of 5-HT, forskolin also failed to affect the EPSP (103 ± 7%; n = 6; Fig.4B).

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Antagonism of Iso- and forskolin-induced potentiation by 5-HT. Application of 5-HT (10 μm) reduced synaptic responses. Subsequent addition of Iso (15 μm) (A) or forskolin (25 μm) (B) in the presence of 5-HT failed to potentiate the EPSP.

We sought to clarify which 5-HT receptor subtype was involved in the inhibition of synaptic transmission and forskolin-induced potentiation. Figure 5A shows that the depression of EPSP produced by 5-HT was blocked by the selective 5-HT1A receptor antagonist 1-(2-methoxyphenyl)-4[4-(2-phthalimido)butyl]piperazine (NAN-190, 2 μm). In the presence of 5-HT and NAN-190, forskolin potentiated the EPSP amplitude to 196 ± 13% (n = 6) of control, which was not significantly different from that without 5-HT + NAN-190. Furthermore, the selective 5-HT1A receptor agonist 8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 10 μm) reversibly depressed the EPSP amplitude to 53 ± 5% of baseline and, in the presence of 8-OH-DPAT, forskolin failed to affect the EPSP amplitude (103 ± 10%; n = 6; Fig. 5B).

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

The effect of 5-HT is blocked by the selective 5-HT1A receptor antagonist and is mimicked by the selective 5-HT1A agonist. A, In the presence of NAN-190 (2 μm), 5-HT did not affect the EPSP significantly. Subsequent application of forskolin (25 μm) induced potentiation. Inset shows superimposed traces taken at the time points indicated.B, Application of 8-OH-DPAT (10 μm) mimicked 5-HT in reducing synaptic responses. Subsequent addition of forskolin (25 μm) in the presence of 8-OH-DPAT failed to potentiate the EPSP.

Cross-talk mechanism between 5-HT and β-adrenergic receptors

We intended to identify the level in the second messenger cascade at which the cross-talk between 5-HT and β-adrenergic receptors took place. If the cross-talk occurred at the enzyme adenylyl cyclase, then 5-HT could not block the effect of cAMP analog. On the other hand, if the cross-talk took place at the level downstream from cAMP production, then 5-HT should be able to inhibit the effect of cAMP analog. These experiments were performed in the presence of IBMX to prevent the degradation of cAMP analog and to block adenosine A1receptors. Figure 6 shows that Sp-cAMPS + IBMX no longer induced potentiation in slices pretreated with 5-HT; EPSP amplitudes were 10.2 ± 0.6 mV for control and 9.6 ± 0.6 mV (n = 6) 40 min after washout of Sp-cAMPS + IBMX. These results indicate that the action is downstream of cAMP production; likely at the Ca2+ channels or the release processes.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Antagonism of Sp-cAMPS-induced LTP by 5-HT. Application of 5-HT (10 μm) depressed the EPSP. Subsequent application of Sp-cAMPS (25 μm) + IBMX (50 μm) failed to potentiate the EPSP.

Thus, it is possible that 5-HT may block Iso-induced potentiation by inhibiting Ca2+ influx. This hypothesis is supported by our recent report showing that activation of 5-HT1Areceptors in the amygdala depressed synaptic transmission primarily by inhibiting presynaptic Ca2+ channels (Cheng et al., 1998). If this is the case, we predicted that (1) buffering intraterminal Ca2+ with chelator should be able to block Iso-induced potentiation; (2) 5-HT should be able to depress synaptic transmission in forskolin-treated slices because its action is downstream of cAMP production; and (3) neurotransmitters that have been shown to inhibit Ca2+ channels are expected to reduce forskolin-induced potentiation too.

First, as demonstrated in Figure7A, application of membrane-permeant Ca2+ chelator BAPTA-AM, which concentration dependently decreased the amplitude of EPSP, virtually abolished Iso-induced potentiation. To differentiate presynaptic or postsynaptic sites of action, we loaded the recorded postsynaptic neuron with BAPTA salt. After impalement, the cells were allowed to stabilize for at least 30 min to allow the cell to fill with BAPTA, which was manifested by blockade of slow afterhyperpolarization. Baseline responses were then obtained for a further 10 min before superfusing Iso. As shown in Figure 7B, Iso still induced a potentiation under this condition (control, 5.2 ± 0.5 mV; 25 min after treatment with 15 μm Iso, 13.0 ± 1.5 mV,n = 6, p < 0.001), suggesting a rise in intraterminal Ca2+ is required for the action of Iso.

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

A rise in intraterminal Ca2+ is required for the Iso-induced potentiation. A, Superfusion of BAPTA-AM concentration-dependently depressed the EPSP and abolished Iso-induced potentiation. The amplitude of EPSP was plotted against time. Bars denote the periods of delivery of BAPTA-AM and 15 μm Iso. B, The effect of Iso was not affected by intracellular BAPTA. Electrodes were filled with BAPTA (50 mm) as described in Materials and Methods.

Second, as shown in Figure 8, when forskolin (50 μm) was superfused into the bath, field potentials increased gradually. Subsequent addition of 5-HT (30 μm) reduced the slope of field potentials by 61 ± 2% (n = 6), not significantly different from that observed without forskolin pretreatment (63 ± 6%;n = 6). Thus, PKA pretreatment did not affect the action of 5-HT. Thirdly, we examined the effects of activation of adenosine A1 and GABAB receptors, two receptors known to inhibit Ca2+ channels (Pfrieger et al., 1994; Wu and Saggau, 1994, 1995) on the forskolin-induced potentiation. Superfusion of N6-cyclopentyladenosine (CPA, 0.5 μm), an adenosine A1 receptor agonist, depressed the EPSP amplitude to 62 ± 6% of baseline (n = 6). However, it can be seen from Figure9, the effect of forskolin (25 μm) was completely blocked in the presence of CPA. Similar experiments were performed for baclofen, a GABABreceptor agonist. Figure 9 shows that application of baclofen (5 μm) nearly abolished the EPSP. Subsequent addition of forskolin (25 μm) no longer induced potentiation.

Fig. 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 8.

Forskolin pretreatment did not affect the action of 5-HT. As forskolin (50 μm) was perfused into the bath, the amplitude of field potential gradually increased. Thirty minutes after application of forskolin, 5-HT (30 μm) was added, which still exerted an average of 61 ± 2% inhibition.

Fig. 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 9.

Antagonistic effect of 5-HT on the forskolin-induced LTP is mimicked by adenosine A1 or GABAB receptor agonists. Application of CPA (0.5 μm) or baclofen (5 μm) depressed the EPSP. Subsequent addition of forskolin (25 μm) in the presence of these agonists failed to potentiate the EPSP.

DISCUSSION

In the present study, we intend to accomplish two goals. First, we wish to identify the intracellular mechanism by which Iso produces long-term enhancement of EPSP. Second, we wish to illuminate any convergence between the 5-HT-induced EPSP inhibition and Iso-induced enhancement.

PKA-mediated synaptic enhancement

Our previous report has shown that when Iso was perfused into the bath, the amplitude of EPSP began to increase in 2–3 min. The Iso effect was long-lasting and was blocked by the antagonist propranolol; besides, it did not affect the resting membrane potential or neuronal input resistance (Huang et al., 1996). The long-latency of Iso action and its sustained effect suggested that a chain of biochemical steps involving second messengers might be the mechanism leading to the enhancement. In the present study, we have demonstrated that forskolin but not 1,9-dideoxy-forskolin mimics the effect of Iso. Similarly, activation of PKA by Sp-cAMPS results in a potentiation. Furthermore, the effect of forskolin was blocked by KT 5720 or Rp-cAMPS, the respective PKA catalytic and regulatory site inhibitors. These results suggest that PKA mediates the enhancement of EPSP by Iso in the amygdala.

Iso-induced potentiation was blocked in Ca2+-free solution or by specific P/Q type Ca2+ channel blockers (Huang et al., 1996), suggesting that potentiation required Ca2+ entry into presynaptic terminals. Of the known adenylyl cyclases, type 1 calmodulin-sensitive adenylyl cyclase (AC1) is stimulated directly by Ca2+ and is synergistically stimulated by combination of Ca2+and receptor activation. In view of the fact that AC1 is neurospecific, expressed in the amygdala (Xia et al., 1991), and is important for synaptic plasticity (Mons and Cooper, 1995; Xia and Storm, 1997; Storm et al., 1998; Villacres et al., 1998), it is hypothesized that entry of Ca2+ into the presynaptic terminal activates AC1, resulting in an increase in intracellular cAMP and activation of PKA, which subsequently phosphorylates Ca2+ channels and causes a persistent increase in glutamate release.

PKA-mediated synaptic potentiation has been described in several brain areas, including hippocampal mossy fiber-CA3 synapses and cerebellar parallel fiber–Purkinje cell synapses (Huang et al., 1994; Weisskopf et al., 1994; Salin et al., 1996). It is suggested that modulation of these synapses by PKA occurs via presynaptic mechanisms that do not alter Ca2+ entry; PKA may directly modulate the secretory processes, or the silent release sites are activated by PKA (Trudeau et al., 1996; Chen and Regehr, 1997; Chavis et al., 1998). This study is one of a few examples in which modulation of presynaptic Ca2+ channels contributes to synaptic enhancement (McGehee et al., 1995).

Blockade of β-adrenergic response by 5-HT1A

5-HT1A receptors are representative of a family of neurotransmitter receptors known to couple functionally to Gi/o proteins to inhibit adenylyl cyclase (Andrade et al., 1986). We have shown that activation of presynaptic 5-HT1Areceptors reduces transmitter release in the basolateral amygdala (Cheng et al., 1998). Previous biochemical studies have shown that activation of Gi-linked receptors inhibited forskolin-stimulated adenylyl cyclase (Cooper et al., 1980; Fredholm et al., 1985; Taissig et al., 1993) and, on the other hand, enhanced the ability of β-adrenergic receptors to generate cAMP (Tang et al., 1991). It was suggested that activation of these Gi-linked receptors led to liberation of βγ complex, which alone had no effect on adenylyl cyclase but potentiated Gsα-stimulated adenylyl cyclase II activity. This hypothesis was supported recently by the electrophysiological studies showing that 5-HT1A,GABAB, and α-adrenergic receptor agonists enhanced β-adrenergic-mediated reduction in the IAHP in rat hippocampal CA1 neurons (Andrade, 1993; Pedarzani and Storm, 1996). In the present study, we have shown that 5-HT inhibited synaptic transmission and completely blocked Iso-induced potentiation. Blockade of Iso-induced potentiation by 5-HT could be prevented by NAN-190, indicating its mediation by 5-HT1A receptors. Our data suggest antagonistic interaction between 5-HT and β-adrenergic receptors. Interestingly, Sp-cAMPS alone depressed the EPSP without inducing potentiation after its washout. Only in the presence of IBMX did Sp-cAMPS induce LTP. These results suggest that Sp-cAMPS may act as an adenosine A1 agonist and further support the antagonistic relationship between adenosine A1 and β-adrenergic receptors. Finally, our results, although in contrast to the hypothesis suggested by Andrade (1993), are consistent with the report of Gerber and Gahwiler (1994), who showed that the action of Iso on IAHP was curtailed significantly by GABAB or adenosine A1 receptor agonists in rat hippocampal CA3 neurons.

Cross-talk mechanism

In principle, the cross-talk described in the present study might occur at any steps involving the modulation of β-adrenergic receptor, G-proteins, adenylyl cyclase, cAMP metabolism, PKA, Ca2+ channels, or the release processes. However, the enhancement of EPSP induced by activation of β-receptor, direct stimulation of adenylyl cyclase by forskolin, or application of cAMP analog was completely blocked in the presence of 5-HT. These results indicate that the interaction between the intracellular signaling pathways activated by 5-HT and Iso occurs at a step downstream from cAMP production. Indeed, several lines of evidence support this hypothesis. First, buffering intraterminal Ca2+ with membrane-permeant Ca2+ chelator blocked Iso-induced potentiation. This finding coupled with our previous observation that 5-HT inhibits glutamate release via a presynaptic blockade of Ca2+ influx suggests that signaling pathways activated by these two receptors may converge at presynaptic Ca2+ channels. Second, If 5-HT action depends on adenylyl cyclase (AC) inhibition, there should be a simple summation of agonist and AC inhibitor effects. Because forskolin produced a 88% increase in EPSP amplitude, and 5-HT decreased EPSP amplitude by 48%, the sum result would be an increase of ∼40%. In fact, pretreatment with 5-HT completely blocked the forskolin enhancement. More importantly, 5-HT depressed the normal and forskolin-enhanced EPSP to the similar extent (∼50%), indicating that 5-HT directly targets Ca2+ channels. Moreover, an important note from Figure 8 is that delayed application of 5-HT in forskolin-pretreated slices depressed the EPSP in a reversible manner. These results indicate that 5-HT blocks the induction but not the expression of forskolin-induced potentiation.

Finally, adenosine A1 and GABAB receptor agonists, which have been shown to depress transmitter release by inhibiting presynaptic Ca2+ channels (Pfrieger et al., 1994; Wu and Saggau, 1994, 1995), also blocked forskolin-induced potentiation.

Functional implication

The functional role of cross-talk explored here is not clear. Because cAMP induces or enhances epileptiform activity (Yokoyama et al., 1989; Boulton et al., 1993), and elevation of cAMP levels are measured in amygdala-kindled animals (Mori, 1983), it is expected that 5-HT1A receptors may have physiological consequence of reducing the response to prolonged excitatory synaptic inputs and act as an anticonvulsant in the amygdala.

Footnotes

  • This study was supported by the National Science Council of Taiwan (NSC86-2314-B006-002-M10).

    Correspondence should be addressed to Dr. Po-Wu Gean at the above address.

REFERENCES

  1. ↵
    1. Andrade R
    (1993) Enhancement of β-adrenergic responses by Gi-linked receptors in rat hippocampus. Neuron 10:83–88.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Andrade R,
    2. Malenka RC,
    3. Nicoll RA
    (1986) A G-protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science 234:1261–1265.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Boulton CL,
    2. McCrohan CR,
    3. O’Shoughnessy CT
    (1993) Cyclic AMP analogues increase excitability and enhance epileptiform activity in rat neocortex in vitro. Eur J Pharmacol 236:131–136.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Chavis P,
    2. Mollard P,
    3. Bockaert J,
    4. Manzoni O
    (1998) Visualization of cyclic AMP-regulated presynaptic activity at a cerebellar granule cells. Neuron 20:773–781.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Chen C,
    2. Regehr WG
    (1997) The mechanism of cAMP-mediated enhancement at a cerebellar synapse. J Neurosci 17:8687–8694.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Cheng LL,
    2. Wang SJ,
    3. Gean PW
    (1998) Serotonin depresses excitatory synaptic transmission and depolarization-evoked Ca++ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci 10:2163–2172.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Cooper DMF,
    2. Londos C,
    3. Rodbell R
    (1980) Adenosine receptor-mediated inhibition of rat cerebral adenylyl cyclase by a GTP-dependent process. Mol Pharmacol 18:598–601.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. De Vivo M,
    2. Maayani S
    (1986) Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylyl cyclase activity in guinea-pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248–253.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Dunwiddie TV,
    2. Hoffer BJ
    (1980) Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br J Pharmacol 69:59–68.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Fernandes LB,
    2. Fryer AD,
    3. Hirshman CA
    (1992) M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J Pharmacol Exp Ther 262:119–124.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Fredholm BB,
    2. Jonzon B,
    3. Lindstrom K
    (1985) Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol 332:173–178.
    OpenUrlCrossRef
  12. ↵
    1. Gerber U,
    2. Gahwiler BH
    (1994) GABAB and adenosine receptors mediate enhancement of the K+ current, IAHP, by reducing adenylyl cyclase activity in rat CA3 hippocampal neurons. J Neurophysiol 72:2360–2367.
    OpenUrlPubMed
  13. ↵
    1. Huang CC,
    2. Hsu KS,
    3. Gean PW
    (1996) Isoproterenol potentiates synaptic transmission primarily by enhancing presynaptic calcium influx via P- and/or Q-type calcium channels in the rat amygdala. J Neurosci 16:1026–1033.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Huang Y-Y,
    2. Li XC,
    3. Kandel ER
    (1994) cAMP contributes to mossy fiber LTP by initiating both a covalently modified early phase and macromolecular synthesis-dependent late phase. Cell 79:69–79.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Lurenza A,
    2. McHugh Sutkowski E,
    3. Seamon KB
    (1989) Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci 10:442–447.
    OpenUrlCrossRefPubMed
  16. ↵
    1. McGehee DS,
    2. Heath MJ,
    3. Gelber S,
    4. Devay P,
    5. Role LW
    (1995) Nicotine enhancement of fast excitatory synaptic transmission in the CNS by presynaptic receptors. Science 269:1692–1696.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Mons N,
    2. Cooper DMF
    (1995) Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci 18:536–542.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Mori N
    (1983) Long-lasting increase of regional cAMP and cGMP in amygdaloid kindled rat brain. J Jpn Epil Soc 1:79–87.
    OpenUrl
  19. ↵
    1. Pedarzani P,
    2. Storm JF
    (1996) Interaction between α- and β-adrenergic receptor agonists modulating the slow Ca++-activated K+ current IAHP in hippocampal neurons. Eur J Neurosci 8:2098–2110.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Pfrieger FW,
    2. Gottmann K,
    3. Lux HD
    (1994) Kinetics of GABAB receptor-mediated inhibition of calcium currents and excitatory synaptic transmission in hippocampal neurons. Neuron 12:97–107.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Pockett S,
    2. Slack JR,
    3. Peacock S
    (1993) Cyclic AMP and long-term potentiation in the CA1 region of rat hippocampus. Neuroscience 52:229–236.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Rainnie DG
    (1995) Serotonergic modulation of synaptic transmission in the basolateral amygdala. Soc Neurosci Abstr 21:1569.
    OpenUrl
  23. ↵
    1. Salin PA,
    2. Malenka RC,
    3. Nicoll RA
    (1996) Cyclic AMP mediates a presynaptic form of LTP at cerebellar parallel fiber synapses. Neuron 16:797–803.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Storm DR,
    2. Hansel C,
    3. Hacker B,
    4. Parent A,
    5. Linden DJ
    (1998) Impaired cerebellar long-term potentiation in type 1 adenylyl cyclase mutant mice. Neuron 20:1199–1210.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Tang W-J,
    2. Gilman AG
    (1991) Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science 254:1500–1503.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Taussig R,
    2. Iniguez-Lluhi JA,
    3. Gilman AG
    (1993) Inhibition of adenylyl cyclase by Giα. Science 261:218–221.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Trudeau LE,
    2. Emery DG,
    3. Haydon PG
    (1996) Direct modulation of the secretory machinery underlies PKA-dependent synaptic facilitation in hippocampal neurons. Neuron 17:789–797.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Villacres EC,
    2. Wong ST,
    3. Chavkin C,
    4. Storm DR
    (1998) Type 1 adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation. J Neurosci 18:3186–3194.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Weisskopf MG,
    2. Castillo PE,
    3. Zalutsky RA,
    4. Nicoll RA
    (1994) Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science 265:1878–1882.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Wu LG,
    2. Saggau P
    (1994) Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12:1139–1148.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Wu LG,
    2. Saggau P
    (1995) GABAB receptor-mediated presynaptic inhibition in guinea-pig hippocampus is caused by reduction of presynaptic Ca++ influx. J Physiol (Lond) 485:649–657.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Xia Z,
    2. Refsdal CD,
    3. Merchant KM,
    4. Dorsa DM,
    5. Storm DR
    (1991) Distribution of mRNA for the calmodulin-sensitive adenylyl cyclase in rat brain: expression in areas associated with learning and memory. Neuron 6:431–443.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Xia Z,
    2. Storm DR
    (1997) Calmodulin-regulated adenylyl cyclases and neuromodulation. Curr Opin Neurobiol 7:391–396.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Yokoyama N,
    2. Mori N,
    3. Kumashiro H
    (1989) Chemical kindling induced by cAMP and transfer to electrical kindling. Brain Res 492:158–162.
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 19 (2)
Journal of Neuroscience
Vol. 19, Issue 2
15 Jan 1999
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cross-Modulation of Synaptic Plasticity by β-Adrenergic and 5-HT1A Receptors in the Rat Basolateral Amygdala
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Cross-Modulation of Synaptic Plasticity by β-Adrenergic and 5-HT1A Receptors in the Rat Basolateral Amygdala
Su-Jane Wang, Li-Liang Cheng, Po-Wu Gean
Journal of Neuroscience 15 January 1999, 19 (2) 570-577; DOI: 10.1523/JNEUROSCI.19-02-00570.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Cross-Modulation of Synaptic Plasticity by β-Adrenergic and 5-HT1A Receptors in the Rat Basolateral Amygdala
Su-Jane Wang, Li-Liang Cheng, Po-Wu Gean
Journal of Neuroscience 15 January 1999, 19 (2) 570-577; DOI: 10.1523/JNEUROSCI.19-02-00570.1999
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • serotonin
  • isoproterenol
  • cAMP
  • protein kinase A
  • calcium channel
  • long-term potentiation
  • amygdala

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Emotion Processing in Chimeric Faces: Hemispheric Asymmetries in Expression and Recognition of Emotions
  • Gating of Hippocampal-Evoked Activity in Prefrontal Cortical Neurons by Inputs from the Mediodorsal Thalamus and Ventral Tegmental Area
  • Cytoskeletal and Morphological Alterations Underlying Axonal Sprouting after Localized Transection of Cortical Neuron AxonsIn Vitro
Show more ARTICLE
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.